Recursion Pharmaceuticals (RECL.L) has surged to record highs this week, driven by a wave of buying interest that appears disconnected from any specific corporate catalyst.
The stock’s rapid ascent has prompted some traders to take profits, with reports indicating that positions are being closed out after delivering triple-digit returns.
The move comes as the artificial intelligence theme continues to dominate market sentiment.
Global semiconductor equities recently posted strong gains, fueled by robust financial results from major US technology manufacturers and a renewed wave of investor confidence in the sector.
Recursion, which leverages AI for drug discovery, has been riding this broader tailwind, even as the specific drivers for its latest spike remain unclear.
The rally highlights the speculative nature of the current AI trade, where momentum often outpaces fundamental news.